Difference between revisions of "Part:BBa K364309"
(14 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
− | |||
__NOTOC__ | __NOTOC__ | ||
<partinfo>BBa_K364309 short</partinfo> | <partinfo>BBa_K364309 short</partinfo> | ||
− | + | ER-α is a 17β-estradiol-activated steroid receptor member of the nuclear receptor superfamily of transcription factors. It has a variety of central physiological roles, including those involved in maintenance of the reproductive, cardiovascular, musculoskeletal and central nervous systems. ER-α is expressed at low to moderate levels in major physiological systems (central nervous system (CNS), endocrine, metabolic, gastrointestinal, immune, reproductive, cardiovascular, respiratory and structural), with peaks of expression in the pituitary, ovary, uterus and vas deferens. ER-α dysfunction is associated with cancer, cardiovascular system defects, hematological system defects, immune and inflammation diseases, metabolic defects, reproductive defects. | |
− | + | ||
+ | More on ER here: [http://en.wikipedia.org/wiki/Estrogen_receptor]. | ||
+ | |||
+ | ER Uniprot: [http://www.uniprot.org/uniprot/P03372]. | ||
+ | |||
+ | View ER LBD crystal structure here: [http://www.rcsb.org/pdb/explore/jmol.do?structureId=2QGT&bionumber=1]. | ||
+ | |||
+ | [[Image:ER-LBD DIMER with estradiol.jpg|800px|thumb|center|Crystal structure of the estrogen receptor alpha ligand binding domain complexed with an ether estradiol compound]] | ||
+ | |||
+ | Description of the ER LBD LBD crystal structure with reference here: [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659626/?tool=pubmed]. | ||
+ | |||
+ | |||
+ | [[Image:ERLBD.jpg|800px|thumb|center|Picture of gel electrophoresis: ER LBD in pSB1C3 results a 828 bp long insert.]] | ||
Latest revision as of 21:03, 26 October 2010
Human ER LBD
ER-α is a 17β-estradiol-activated steroid receptor member of the nuclear receptor superfamily of transcription factors. It has a variety of central physiological roles, including those involved in maintenance of the reproductive, cardiovascular, musculoskeletal and central nervous systems. ER-α is expressed at low to moderate levels in major physiological systems (central nervous system (CNS), endocrine, metabolic, gastrointestinal, immune, reproductive, cardiovascular, respiratory and structural), with peaks of expression in the pituitary, ovary, uterus and vas deferens. ER-α dysfunction is associated with cancer, cardiovascular system defects, hematological system defects, immune and inflammation diseases, metabolic defects, reproductive defects.
More on ER here: [http://en.wikipedia.org/wiki/Estrogen_receptor].
ER Uniprot: [http://www.uniprot.org/uniprot/P03372].
View ER LBD crystal structure here: [http://www.rcsb.org/pdb/explore/jmol.do?structureId=2QGT&bionumber=1].
Description of the ER LBD LBD crystal structure with reference here: [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659626/?tool=pubmed].
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]